Govinda J. Weerakkody - Researcher Profile

Publications

3 shown

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Stephen D. Wiviott , Eugene Braunwald , Carolyn H. McCabe +11 more

In patients with acute coronary syndromes with scheduled percutaneous coronary intervention, prasugrel therapy was associated with significantly reduced rates of ischemic events...

2007 New England Journal of Medicine 6636 citations

Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y <sub>12</sub> Antagonist, With Clopidogrel in Percutaneous Coronary Intervention

Stephen D. Wiviott , Elliott M. Antman , Kenneth J. Winters +8 more

Background— Despite the current standard antiplatelet regimen of aspirin and clopidogrel (with or without glycoprotein IIb/IIIa inhibitors) in percutaneous coronary intervention...

2005 Circulation 378 citations

Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)

Stephen D. Wiviott , Elliott M. Antman , C. Michael Gibson +7 more

2006 American Heart Journal 326 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 7,340
Institution: Eli Lilly (United States)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-0595-5554

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.